A digital health leader revolutionizing AI-driven cardiometabolic care, today announced its selection by Modern Healthcare as one of the 2025 Best Places to Work in Healthcare. This national award recognizes top…
Altera Digital Health Launches Sunrise 25.1 for Hospitals and Health Systems Altera Digital Health, a global health IT leader, today announced the general availability of Sunrise™ 25.1, the latest release of…
SMART METER SELECTED BY 9AMHEALTH FOR MAJOR EMPLOYER WEIGHT MANAGEMENT PROGRAMS USING CELLULAR WEIGHT SCALE Smart Meter, a pioneer in cellular-enabled weight scale technology, today announced a strategic supply agreement…
SynergenX, a national leader revolutionizing hormone therapy, TRT, weight loss, and wellness services, is proud to announce the launch of the SynergenX App, now available for free download on the Apple…
The “Companion Diagnostic Markets 2025-2029: The Future of Diagnostics by Application, Technology and Funding with Executive & Consultant Guides” report has been added to ResearchAndMarkets.com’s offering. Companion Diagnostics are changing the diagnostics industry. Whole…
Kerecis, the company pioneering the use of sustainably sourced fish skin in cellular therapy and tissue regeneration, announces that Blue Cross and Blue Shield of Louisiana (BCBSLA) has added Kerecis…
The National Evaluation System for health Technology (NEST), an initiative of the Medical Device Innovation Consortium (MDIC), is pleased to welcome Hologic, a leading global medical device and diagnostic company,…
NUBURU, Inc. (NYSE American: BURU), a leader in high-power blue laser technology under a pivotal transformation plan, entered into a standby equity purchase agreement (the “Agreement”) with YA II PN,…
Actym Therapeutics, a clinical-stage therapeutic product development and platform company, announced the issuance of US patent Nos. 12,201,653 and 12,226,439 by the United States Patent and Trademark Office. These patents…
Hyperfine’s Next-Gen Swoop® with Optive AI™ Gets FDA Clearance Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI…
–Lightcast, a pioneering life science tools company, today announced the appointment of Philip Binns as chairman of its board of directors, effective May 1, 2025. With this appointment, the Lightcast…
–Revvity, Inc. (NYSE: RVTY), today announced the launch of three Mimix™ reference standards for IVD use, designed for monitoring of next-generation sequencing (NGS) or droplet digital polymerase chain reacting (ddPCR) assays…